{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:18:48Z","timestamp":1779913128025,"version":"3.53.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sirgartan Therapeutics Ltd","award":["Sirgartan Therapeutics Ltd"],"award-info":[{"award-number":["Sirgartan Therapeutics Ltd"]}]},{"name":"Sirgartan Therapeutics Ltd","award":["Sirgartan Therapeutics Ltd"],"award-info":[{"award-number":["Sirgartan Therapeutics Ltd"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale<\/jats:title>\n            <jats:p>Obsessive-compulsive disorder (OCD) affects 1\u20133% of the population. Current therapies, including selective serotonin reuptake inhibitors, are not universally effective in managing OCD. Recent discoveries indicating hyperactivation of key regions within the corticostriatal thalamic circuitry that supports OCD, and alterations in the ratio of glutamate: GABA in regions such as the anterior cingulate cortex, suggest that drugs targeting glutamatergic signalling may be effective in reducing OCD symptoms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>This study sought to determine whether two drugs targeting metabotropic glutamate receptors could reduce excessive checking behaviour in a rodent analogue of compulsive-like checking in OCD, the Observing Response Task (ORT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Rats were trained on the ORT and separately classified on a pavlovian autoshaping task to identify the subpopulation of sign-trackers, which show higher levels of excessive checking. Once responding had stabilised, rats received systemic administration of different doses of the mGluR2 positive allosteric modulator AZD-8529 and its vehicle in a Latin square design, and the effects on ORT performance were assessed. Following completion of AZD-8529 dosing, a subset of rats received administration of different doses of the mGluR2\/3 agonist LY404039 and its vehicle in a Latin square design, and ORT performance assessed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Both AZD-8529 and LY404039 produced dose-dependent reductions in checking behaviour, including at doses that did not impair generalised measures of task performance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The similarity in effect of AZD-8529 and LY404039 suggests that the capacity of these drugs to reduce checking is mediated by mGluR2s, which may provide a promising target for future treatment development for OCD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00213-025-06774-2","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T12:43:06Z","timestamp":1743770586000},"page":"1893-1907","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Agonism at mGluR2 receptors reduces dysfunctional checking on a rodent analogue of compulsive-like checking in obsessive compulsive disorder"],"prefix":"10.1007","volume":"242","author":[{"given":"Colin","family":"McKenzie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Sloot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felippe Espinelli","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor W","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0175-9417","authenticated-orcid":false,"given":"Amy L","family":"Milton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"6774_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1471-244X-13-143","volume":"13","author":"DH Adams","year":"2013","unstructured":"Adams DH, Kinon BJ, Baygani S, Millen BA, Velona I, Kollack-Walker S, Walling DP (2013) A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of Pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia. BMC Psychiatry 13:143. https:\/\/doi.org\/10.1186\/1471-244X-13-143","journal-title":"BMC Psychiatry"},{"key":"6774_CR2","doi-asserted-by":"publisher","first-page":"e50978","DOI":"10.3791\/50978","volume":"82","author":"M Angoa-P\u00e9rez","year":"2013","unstructured":"Angoa-P\u00e9rez M, Kane MJ, Briggs DI, Francescutti DM, Kuhn DM (2013) Marble burying and nestlet shredding as tests of repetitive, compulsive-like behaviors in mice. J Visualized Experiments 82:e50978. https:\/\/doi.org\/10.3791\/50978","journal-title":"J Visualized Experiments"},{"key":"6774_CR3","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1046\/j.1460-9568.2003.02657.x","volume":"17","author":"E Aronica","year":"2003","unstructured":"Aronica E, Gorter JA, Ijlst-Keizers H, Rozemuller AJ, Yankaya B, Leenstra S, Troost D (2003) Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins. Eur J Neurosci 17:2106\u20132118. https:\/\/doi.org\/10.1046\/j.1460-9568.2003.02657.x","journal-title":"Eur J Neurosci"},{"key":"6774_CR4","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/npp.2009.77","volume":"34","author":"S Bhattacharyya","year":"2009","unstructured":"Bhattacharyya S, Khanna S, Chakrabarty K, Mahadevan A, Christopher R, Shankar SK (2009) Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive Diosrder. Neuropsychopharmacology 34:2489\u20132496. https:\/\/doi.org\/10.1038\/npp.2009.77","journal-title":"Neuropsychopharmacology"},{"key":"6774_CR5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.bpsgos.2023.08.009","volume":"4","author":"M Biria","year":"2024","unstructured":"Biria M, Banca P, Keser E, Healy M, Sawiak SJ, Frota Lisb\u00f4a Pereira de Souza AM, Robbins TW (2024) Excessive checking in obsessive-compulsive disorder: neurochemical correlates revealed by 7T magnetic resonance spectroscopy. Biol Psychiatry: Global Open Sci 4:363\u2013373. https:\/\/doi.org\/10.1016\/j.bpsgos.2023.08.009","journal-title":"Biol Psychiatry: Global Open Sci"},{"key":"6774_CR6","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.biopsych.2012.05.028","volume":"72","author":"MH Bloch","year":"2012","unstructured":"Bloch MH, Wasylink S, Landeros-Weisenberger A, Panza KE, Billingslea E, Leckman JF, Pittenger C (2012) Effects of ketamine in treatment-refractory obsessive-compulsive disorder. Biol Psychiatry 72:964\u2013970. https:\/\/doi.org\/10.1016\/j.biopsych.2012.05.028","journal-title":"Biol Psychiatry"},{"issue":"4","key":"6774_CR7","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3758\/BRM.42.4.1059","volume":"42","author":"RN Cardinal","year":"2010","unstructured":"Cardinal RN, Aitken MRF (2010) Whisker: a client-server high-performance multimedia research control system. Behav Res Methods 42(4):1059\u20131071","journal-title":"Behav Res Methods"},{"key":"6774_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bbr.2013.12.040","volume":"264","author":"DM Eagle","year":"2014","unstructured":"Eagle DM, Noschang C, d\u2019Angelo L-SC, Noble C, Day JO, Dongelmans ML, Robbins TW (2014) The dopamine D2\/D3 receptor agonist Quinpirole increases checking-like behaviour in an operant observing response task with uncertain reinforcement: a novel possible model of OCD. Behav Brain Res 264:207\u2013229","journal-title":"Behav Brain Res"},{"key":"6774_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-00020-05636-00213","author":"DM Eagle","year":"2020","unstructured":"Eagle DM, Schepisi C, Chugh S, Desai S, Han S, Huang T, Robbins TW (2020) Dissociable dopaminergic and Pavlovian influences in goal-trackers and sign-trackers on a model of compulsive checking in OCD. Psychopharmacology. https:\/\/doi.org\/10.1007\/s00213-00020-05636-00213","journal-title":"Psychopharmacology"},{"key":"6774_CR10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/YIC.0000000000000237","volume":"33","author":"NA Fineberg","year":"2018","unstructured":"Fineberg NA, Baldwin DS, Drummond LM, Wyatt S, Hanson J, Gopi S, Wellsted D (2018) Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder. Int Clin Psychopharmacol 33:334\u2013348. https:\/\/doi.org\/10.1097\/YIC.0000000000000237","journal-title":"Int Clin Psychopharmacol"},{"key":"6774_CR11","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/cercor\/bhx005","volume":"28","author":"LE Jin","year":"2018","unstructured":"Jin LE, Wang M, Galvin VC, Lightbourne TC, Conn PJ, Arnsten AFT, Paspalas CD (2018) mGluR2 versus mGluR3 metabotropic glutamate receptors in primate dorsolateral prefrontal cortex: postsynaptic mGluR3 strengthen working memory networks. Cereb Cortex 28:974\u2013987. https:\/\/doi.org\/10.1093\/cercor\/bhx005","journal-title":"Cereb Cortex"},{"key":"6774_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.biopsych.2015.01.014","volume":"78","author":"Z Justinova","year":"2015","unstructured":"Justinova Z, Panlilio LV, Secci ME, Redhi GH, Schindler CW, Cross AJ, Goldberg SR (2015) The novel metabotropic glutamate receptor 2 positive allosteric modulator, AZD8529, decreases nicotine self-administration and relapse in squirrel monkeys. Biol Psychiatry 78:452\u2013462","journal-title":"Biol Psychiatry"},{"key":"6774_CR13","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.biopsych.2015.03.016","volume":"78","author":"BJ Kinon","year":"2015","unstructured":"Kinon BJ, Millen BA, Zhang L, McKinzie DL (2015) Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2\/3 receptor agonist Pomaglumetad methionil in schizophrenia. Biol Psychiatry 78:754\u2013762. https:\/\/doi.org\/10.1016\/j.biopsych.2015.03.016","journal-title":"Biol Psychiatry"},{"key":"6774_CR14","doi-asserted-by":"publisher","first-page":"152422","DOI":"10.1016\/j.comppsych.2023.152422","volume":"127","author":"N Kochar","year":"2023","unstructured":"Kochar N, Ip S, Vardanega V, Sireau NT, Fineberg NA (2023) A cost-of-illness analysis of the economic burden of obsessive-compulsive disorder in the united Kingdom. Compr Psychiatr 127:152422. https:\/\/doi.org\/10.1016\/j.comppsych.2023.152422","journal-title":"Compr Psychiatr"},{"issue":"12","key":"6774_CR15","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.tins.2016.10.005","volume":"39","author":"G Lassi","year":"2016","unstructured":"Lassi G, Taylor AE, Timpson NJ, Kenny PJ, Mather RJ, Eisen T, Munaf\u00f2 MR (2016) The CHRNA5-A3-B4 gene cluster and smoking: from discovery to therapeutics. Trends Neurosci 39(12):851\u2013861. https:\/\/doi.org\/10.1016\/j.tins.2016.10.005","journal-title":"Trends Neurosci"},{"key":"6774_CR16","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s00213-016-4220-2","volume":"233","author":"X Li","year":"2016","unstructured":"Li X, D\u2019Souza MS, Ni\u00f1o AM, Doherty J, Cross A, Markou A (2016) Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 positive allosteric modulators AZD8418 and AZD8529 in rats. Psychopharmacology 233:1801\u20131814. https:\/\/doi.org\/10.1007\/s00213-016-4220-2","journal-title":"Psychopharmacology"},{"key":"6774_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.schres.2016.02.001","volume":"172","author":"RE Litman","year":"2016","unstructured":"Litman RE, Smith MA, Doherty JJ, Cross A, Raines S, Gertsik L, Zukin SR (2016) AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: a proof of principle study. Schizophr Res 172:152\u2013157. https:\/\/doi.org\/10.1016\/j.schres.2016.02.001","journal-title":"Schizophr Res"},{"key":"6774_CR18","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1017\/S0954579408000606","volume":"20","author":"TV Maia","year":"2008","unstructured":"Maia TV, Cooney RE, Peterson BS (2008) The neural bases of obsessive-compulsive disorder in children and adults. Dev Psychopathol 20:1251\u20131283. https:\/\/doi.org\/10.1017\/S0954579408000606","journal-title":"Dev Psychopathol"},{"key":"6774_CR19","doi-asserted-by":"crossref","unstructured":"Mataix-Cols D, Rosario-Campos Concei\u00e7\u00e3o, M., Leckman JF (2005) A multidimensional model of obsessive-compulsive disorder. American Journal of Psychiatry, 162, 228\u2013238","DOI":"10.1176\/appi.ajp.162.2.228"},{"issue":"5","key":"6774_CR20","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.euroneuro.2015.06.030","volume":"26","author":"S Morein-Zamir","year":"2016","unstructured":"Morein-Zamir S, Shahper S, Fineberg NA, Eagle DM, Urcelay G, Mar AC, Robbins TW (2016) OCD patients show increased certainty seeking in an operant observing response task: a translational approach. Eur Neuropsychopharmacol 26(5):896\u2013897. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.06.030","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10","key":"6774_CR21","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1177\/1747021817737727","volume":"71","author":"S Morein-Zamir","year":"2018","unstructured":"Morein-Zamir S, Shahper S, Fineberg NA, Eisele V, Eagle DM, Urcelay G, Robbins TW (2018) Free operant observing in humans: a translational approach to compulsive certainty seeking. Q J Experimental Psychol 71(10):2052\u20132069","journal-title":"Q J Experimental Psychol"},{"issue":"4","key":"6774_CR22","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/0306-4522(93)90485-X","volume":"53","author":"H Ohishi","year":"1993","unstructured":"Ohishi H, Shigemoto R, Nakanishi S, Mizuno N (1993a) Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience 53(4):1009\u20131018","journal-title":"Neuroscience"},{"key":"6774_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/cne.903350209","volume":"335","author":"H Ohishi","year":"1993","unstructured":"Ohishi H, Shigemoto R, Nakanishi S, Mizuno N (1993b) Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study. J Comp Neurol 335:252\u2013266","journal-title":"J Comp Neurol"},{"key":"6774_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.brat.2006.03.004","volume":"45","author":"BO Olatunji","year":"2007","unstructured":"Olatunji BO, Lohr JM, Sawchuk CN, Tolin DF (2007) Multimodal assessment of disgust in contamination-related obsessive-compulsive disorder. Behav Res Ther 45:263\u2013276. https:\/\/doi.org\/10.1016\/j.brat.2006.03.004","journal-title":"Behav Res Ther"},{"key":"6774_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1037\/0735-7044.114.1.42","volume":"114","author":"JA Parkinson","year":"2000","unstructured":"Parkinson JA, Willoughby PJ, Robbins TW, Everitt BJ (2000) Disconnection of the anterior cingulate cortex and nucleus accumbens core impairs Pavlovian approach behavior: further evidence for limbic cortical-ventral striatopallidal systems. Behav Neurosci 114:42\u201363","journal-title":"Behav Neurosci"},{"issue":"9","key":"6774_CR26","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/nm1632","volume":"13","author":"ST Patil","year":"2007","unstructured":"Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV, Schoepp DD (2007) Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial. Nat Med 13(9):1102\u20131107. https:\/\/doi.org\/10.1038\/nm1632","journal-title":"Nat Med"},{"key":"6774_CR27","doi-asserted-by":"publisher","DOI":"10.3758\/s13415-023-01153-w","author":"L Pickenhan","year":"2024","unstructured":"Pickenhan L, Milton AL (2024) Opening new vistas on obsessive-compulsive disorder with the observing response task. Cogn Affect Behav Neurosci 24:249\u2013265. https:\/\/doi.org\/10.3758\/s13415-023-01153-w","journal-title":"Cogn Affect Behav Neurosci"},{"issue":"6","key":"6774_CR28","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3928\/00485713-20150602-06","volume":"46","author":"C Pittenger","year":"2015","unstructured":"Pittenger C (2015) Glutamate modulators in the treatment of obsessive-compulsive disorder. Psychiatric Annals 46(6):308\u2013315. https:\/\/doi.org\/10.3928\/00485713-20150602-06","journal-title":"Psychiatric Annals"},{"key":"6774_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.pharmthera.2011.09.006","volume":"132","author":"C Pittenger","year":"2011","unstructured":"Pittenger C, Bloch MH, Williams K (2011) Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther 132:314\u2013332. https:\/\/doi.org\/10.1016\/j.pharmthera.2011.09.006","journal-title":"Pharmacol Ther"},{"key":"6774_CR30","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.brat.2003.07.001","volume":"42","author":"AS Radomsky","year":"2004","unstructured":"Radomsky AS, Rachman S (2004) Symmetry, ordering and arranging compulsive behaviour. Behav Res Ther 42:893\u2013913. https:\/\/doi.org\/10.1016\/j.brat.2003.07.001","journal-title":"Behav Res Ther"},{"key":"6774_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuron.2019.01.046","volume":"102","author":"TW Robbins","year":"2019","unstructured":"Robbins TW, Vaghi MM, Banca P (2019) Obsessive-compulsive disorder: puzzles and prospects. Neuron 102:27\u201347. https:\/\/doi.org\/10.1016\/j.neuron.2019.01.046","journal-title":"Neuron"},{"key":"6774_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bbr.2006.03.032","volume":"171","author":"ZA Rodd","year":"2006","unstructured":"Rodd ZA, McKinzie DL, Bell RL, McQueen VK, Murphy JM, Schoepp DD, McBride WJ (2006) The metabotropic glutamate 2\/3 receptor agonist LY404039 reduces alcohol-seeking but not alcohol self-administration in alcohol-preferring (P) rats. Behav Brain Res 171:207\u2013215. https:\/\/doi.org\/10.1016\/j.bbr.2006.03.032","journal-title":"Behav Brain Res"},{"key":"6774_CR33","doi-asserted-by":"publisher","unstructured":"Rodriguez CI, Kegeles LS, Flood P, Blair Simpson H (2011) Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry 72(4):567\u2013569. https:\/\/doi.org\/10.4088\/JCP.10|06653.","DOI":"10.4088\/JCP.10|06653."},{"key":"6774_CR34","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1038\/npp.2013.150","volume":"38","author":"CI Rodriguez","year":"2013","unstructured":"Rodriguez CI, Kegeles LS, Levinson A, Feng T, Marcus SM, Vermes D, Simpson HB (2013) Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology 38:2475\u20132483. https:\/\/doi.org\/10.1038\/npp.2013.150","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"6774_CR35","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4088\/JCP.16cr11234","volume":"78","author":"CI Rodriguez","year":"2017","unstructured":"Rodriguez CI, Lapidus KAB, Zwerling J, Levinson A, Mahnke A, Steinman SA, Simpson HB (2017) Challenges in testing intranasal ketamine in obsessive-compulsive disorder. J Clin Psychiatry 78(4):466\u2013467. https:\/\/doi.org\/10.4088\/JCP.16cr11234","journal-title":"J Clin Psychiatry"},{"key":"6774_CR36","doi-asserted-by":"crossref","unstructured":"Rorick-Kehn LM, Johnson BG, Knitowski KM, Salhoff CR, Witkin JM, Perry KW, Schoepp DD (2007) In vivo Pharmacological characterization of the structurally novel, potent, selective mGlu2\/3 receptor agonist LY404039 in animal models of psychiatric disorders. 193:121\u2013136","DOI":"10.1007\/s00213-007-0758-3"},{"key":"6774_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0022-3565(24)29296-X","volume":"299","author":"DD Schoepp","year":"2001","unstructured":"Schoepp DD (2001) Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J Pharmacol Exp Ther 299:12\u201320","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"6774_CR38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0306-4522(01)00305-0","volume":"106","author":"Y Tamaru","year":"2001","unstructured":"Tamaru Y, Nomura S, Mizuno N, Shigemoto R (2001) Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites. Neuroscience 106(3):481\u2013503","journal-title":"Neuroscience"},{"key":"6774_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0896-6273(92)90118-W","volume":"8","author":"Y Tanabe","year":"1992","unstructured":"Tanabe Y, Masu M, Ishii T, Shigemoto R, Nakanishi S (1992) A family of metabotropic glutamate receptors. Neuron 8:169\u2013179","journal-title":"Neuron"},{"issue":"5","key":"6774_CR40","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1523\/JNEUROSCI.14-05-03005.1994","volume":"14","author":"CM Testa","year":"1994","unstructured":"Testa CM, Standaert DG, Young AB, Penney JB (1994) Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J Neurosci 14(5):3005\u20133018","journal-title":"J Neurosci"},{"issue":"5","key":"6774_CR41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1101\/lm.050260.119","volume":"27","author":"GH Vousden","year":"2020","unstructured":"Vousden GH, Paulcan S, Robbins TW, Eagle DM, Milton AL (2020) Checking responses of goal- and sign-trackers are differentially affected by threat in a rodent analogue of obsessive-compulsive disorder. Learn Mem 27(5):190\u2013200","journal-title":"Learn Mem"},{"key":"6774_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.janxdis.2007.02.009","volume":"22","author":"K Wahl","year":"2008","unstructured":"Wahl K, Salkovskis PM, Cotter I (2008) \u2018I wash until it feels right\u2019. The phenomenology of stopping criteria in obsessive-compulsive washing. Anxiety Disord 22:143\u2013161. https:\/\/doi.org\/10.1016\/j.janxdis.2007.02.009","journal-title":"Anxiety Disorders"},{"key":"6774_CR43","doi-asserted-by":"crossref","unstructured":"Wolf DH, Zheng D, Kohler C, Turetsky BI, Ruparel K, Satterthwaite TD, Gur RE (2022) Effect of mGluR2 positive allosteric modulation on frontostriatal working memory activation in schizophrenia. Mol Psychiatry 27(2):1226\u20131232.","DOI":"10.1038\/s41380-021-01320-w"},{"key":"6774_CR44","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Manji HK (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856\u2013864","journal-title":"Arch Gen Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06774-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-025-06774-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06774-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T09:07:40Z","timestamp":1757149660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-025-06774-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["6774"],"URL":"https:\/\/doi.org\/10.1007\/s00213-025-06774-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was regulated under the UK Animals (Scientific Procedures) Act 1986 Amendment Regulations (2012) on Project Licence PA9FBFA9F following ethical review by the University of Cambridge Animal Welfare and Ethical Review Body.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"TWR is a consultant for Cambridge Cognition and is a member of the scientific board of Sirgartan Therapeutics Ltd. CM\u2019s salary was funded by Sirgartan Therapeutics Ltd.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}